Research Topic

Oligomerization and Fibrillation of Amyloid Peptides: Mechanism, Toxicity and Inhibition

About this Research Topic

The pathological process of neurodegenerative diseases, such as Alzheimer's disease, type 2 diabetes, Parkinson’s disease, etc., is closely related to the aggregation of one or more types of amyloid peptides. The amyloid peptides assemble into mature fibril undergoing misfolding, nucleation and elongation stages, and increasing evidences have shown that the neurotoxicity comes from the oligomerization and fibrillation. The formation of amyloid fibrils is influenced by multiple factors (e.g., peptide concentration, ionic strength, temperature, pH, membrane environment, etc.). Still, the dynamics of aggregation, structures of intermediate products, and related toxicity remain elusive. Exploring the aggregation of amyloid peptides and the achievement of effective modulation may facilitate the detection and mitigation of neurodegenerative diseases.

The goal of this Research Topic is to provide an update on the understanding of structural basis and molecular mechanism for amyloid peptide aggregation, with a special emphasis on new insights into the inhibition using nanoparticles, small molecules, metals, etc.

Original research papers, reviews, and short communications covering experimental, theoretical or computational aspects related to the current Research Topic are all warmly welcome. The areas covered by this Research Topic may include but are not limited to:

• Structural basis for the aggregation of amyloid peptides
• Phase separation involved in amyloid aggregation
• Comparison between different amyloid peptides
• Novel inhibitors including nanoparticles, small molecules, metal ions, etc.
• Misfolding and aggregation of amyloid peptides at membrane
• Ligand and amyloid peptide interaction
• Molecular mechanisms on the dynamics of amyloid oligomerization and fibrillation


Keywords: protein aggregation, protein-membrane interaction, protein-nanoparticle interaction, amyloid peptide, inhibitory mechanism


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

The pathological process of neurodegenerative diseases, such as Alzheimer's disease, type 2 diabetes, Parkinson’s disease, etc., is closely related to the aggregation of one or more types of amyloid peptides. The amyloid peptides assemble into mature fibril undergoing misfolding, nucleation and elongation stages, and increasing evidences have shown that the neurotoxicity comes from the oligomerization and fibrillation. The formation of amyloid fibrils is influenced by multiple factors (e.g., peptide concentration, ionic strength, temperature, pH, membrane environment, etc.). Still, the dynamics of aggregation, structures of intermediate products, and related toxicity remain elusive. Exploring the aggregation of amyloid peptides and the achievement of effective modulation may facilitate the detection and mitigation of neurodegenerative diseases.

The goal of this Research Topic is to provide an update on the understanding of structural basis and molecular mechanism for amyloid peptide aggregation, with a special emphasis on new insights into the inhibition using nanoparticles, small molecules, metals, etc.

Original research papers, reviews, and short communications covering experimental, theoretical or computational aspects related to the current Research Topic are all warmly welcome. The areas covered by this Research Topic may include but are not limited to:

• Structural basis for the aggregation of amyloid peptides
• Phase separation involved in amyloid aggregation
• Comparison between different amyloid peptides
• Novel inhibitors including nanoparticles, small molecules, metal ions, etc.
• Misfolding and aggregation of amyloid peptides at membrane
• Ligand and amyloid peptide interaction
• Molecular mechanisms on the dynamics of amyloid oligomerization and fibrillation


Keywords: protein aggregation, protein-membrane interaction, protein-nanoparticle interaction, amyloid peptide, inhibitory mechanism


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

22 May 2021 Abstract
19 September 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

22 May 2021 Abstract
19 September 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..